SOW
JNCE

State of Wyoming’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

State of Wyoming’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,229
Closed -$42K – 2224
2022
Q1 		$42K Buy
6,229
+4,126
+196% +$29.4K 0.02% 1160
2021
Q4 		$18K Buy
+2,103
New +$17.3K 0.01% 1514

Other funds holding JNCE

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

State of Wyoming's JNCE Position: Q2 2022 in Review

State of Wyoming sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2022, closing a stake of 6,229 shares — an estimated $42K sold.

State of Wyoming first reported a position in JNCE in Q4 2021 and held it in 2 quarters. The position peaked at $42K in Q1 2022. 102 funds tracked by Wall St. Rank hold JNCE as of Q2 2022.

  • State of Wyoming reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • State of Wyoming sold 6,229 Jounce Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $42K.
  • State of Wyoming first reported a position in Jounce Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • State of Wyoming's Jounce Therapeutics, Inc. Common Stock position peaked at $42K in Q1 2022.
  • 102 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2022.

Based on State of Wyoming's 13F filing for Q2 2022, filed 15 Aug 2022.